Posterior Sagittal Anorectoplasty (PSARP) for Imperforate Anus
Treatment for Digestive congenital anomalies
Effectiveness
88%
Safety Score
48%
Clinical Trials
1
Participants
8K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
48
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate anatomical correction, functional bowel control develops over 1-3 years
Treatment Duration
Acute (staged surgical), 1-2 weeks hospitalization, long-term follow-up and bowel management (years)
Evidence Quality
MODERATEConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$70,000
Side Effect Mgmt:$10,000
Total Annual:$80,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
65
Outcome-Based Costs
Cost per Responder
$89,444
Cost per Remission
$100,625
Posterior Sagittal Anorectoplasty (PSARP) for Imperforate Anus Outcomes
for Digestive congenital anomalies
Efficacy Outcomes
Overall Effectiveness
+88%
Response Rate
+90%
Remission Rate
+80%
Common Side Effects
Fecal incontinence/soiling
+35%
Constipation
+45%
Anal stricture
+15%
Wound infection
+7%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
1 completed trial for Posterior Sagittal Anorectoplasty (PSARP) for Imperforate Anus in Digestive congenital anomalies
Rectovestibular Fistula Which Surgical Approaches?
NCT04970160COMPLETED
84 participants
OBSERVATIONAL
Started: Jan 1, 2016